These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7162460)

  • 1. The effects of exposure to cytosine arabinoside upon the proliferation of leukemia colony forming units in vitro.
    Preisler HD
    Med Pediatr Oncol; 1982; 10 Suppl 1():149-55. PubMed ID: 7162460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro sensitivity of CFU-L to cytosine arabinoside (Ara-C).
    Marie JP; Zittoun R
    Med Pediatr Oncol; 1982; 10 Suppl 1():263-7. PubMed ID: 6962323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of two methods for determining the sensitivity of human myeloid colony-forming units to cytosine arabinoside.
    Preisler HD; Epstein J
    Br J Haematol; 1981 Apr; 47(4):519-27. PubMed ID: 7213575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged exposure to cytosine arabinoside in the presence of hematopoietic growth factors preferentially kills leukemic versus normal clonogenic cells.
    Van Der Lely N; De Witte T; Muus P; Raymakers R; Preijers F; Haanen C
    Exp Hematol; 1991 May; 19(4):267-72. PubMed ID: 2055291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of busulfan, cytosine arabinoside and adriamycin on different maturation stages of normal human bone marrow cells.
    Tohda S; Nagata K; Suzuki T; Nara N
    Acta Haematol; 1990; 83(1):16-21. PubMed ID: 2105564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evidence for dose-dependent cytotoxicity as the predominant effect of low dose Ara-C on human leukemic and normal marrow cells.
    Chan CS; Schechter GP
    Cancer Chemother Pharmacol; 1989; 23(2):87-94. PubMed ID: 2910516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cytosine arabinoside on DNA synthesis as predictor for acute myelocytic leukemia (AML) patients' response to chemotherapy.
    Epstein J; Preisler H
    Eur J Cancer (1965); 1981 Jun; 17(6):623-8. PubMed ID: 6946929
    [No Abstract]   [Full Text] [Related]  

  • 8. Sensitivity of myeloid progenitor cells in healthy subjects and patients with chronic myeloid leukemia to chemotherapeutic agents.
    Spiro TE; Mattelaer MA; Efira A; Stryckmans P
    J Natl Cancer Inst; 1981 Jun; 66(6):1053-9. PubMed ID: 6941040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytosine arabinoside as a suicide agent for human colony forming cells.
    Dresch C; El Kebir N; Metral J; Karsdorf A
    Exp Hematol; 1983 Mar; 11(3):187-92. PubMed ID: 6832245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro cytostatic effect of adenine-arabinoside (Ara-A) and cytosine-arabinoside (Ara-C).
    Nissen C; Henauer J; Speck B
    Experientia; 1978 Sep; 34(9):1219-20. PubMed ID: 720532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An in vitro chemotherapy sensitivity test on leukemic colony-forming cells (L-CFU) and its clinical evaluation].
    Moriyama Y; Urushiyama M; Hirosawa H; Koyama S; Takai K; Fujiwara M; Kishi K; Takahashi M; Sakai C; Sanada M; Shibata A
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1749-54. PubMed ID: 7184371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cytosine arabinoside on differentiation of normal human bone marrow cells.
    Nagler A; Kletter Y; Ricklis I; Gazit E; Tatarsky I; Fabian I
    Exp Hematol; 1986 Mar; 14(3):241-5. PubMed ID: 2419152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different sensitivity of normal and leukaemic progenitor cells to Ara-C and IL-3 combined treatment.
    Lista P; Brizzi MF; Rossi M; Resegotti L; Clark SC; Pegoraro L
    Br J Haematol; 1990 Sep; 76(1):21-6. PubMed ID: 2223644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of response to chemotherapy in acute myelocytic leukemia.
    Preisler HD
    Blood; 1980 Sep; 56(3):361-7. PubMed ID: 6931620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GM-CSF enhances sensitivity of leukemic clonogenic cells to long-term low dose cytosine arabinoside with sparing of the normal clonogenic cells.
    De Witte T; Muus P; Haanen C; Van der Lely N; Koekman E; Van der Locht A; Blankenborg G; Wessels J
    Behring Inst Mitt; 1988 Aug; (83):301-7. PubMed ID: 3071344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in proliferation rate of human bone marrow colony-forming cells measured by a cytosine arabinoside-diffusion chamber method.
    Gordon MY; Douglas ID
    Eur J Cancer (1965); 1976 Jul; 12(7):551-5. PubMed ID: 954797
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of cytosine arabinoside on DNA synthesis and the clonogenicity of RF/UN murine myeloid leukemia cells.
    Epstein J; Preisler H
    Exp Hematol; 1980 Sep; 8(8):1009-15. PubMed ID: 7202586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and characteristics of colony-forming units fibroblasts (CFU-F) in the bone marrow of weanling mice treated with cytosine arabinoside and phenylhydrazine: correlation with CFU-S, progenitors of diffusion-chamber colonies (CFU-D), and CFU-C.
    Ben-Ishay Z; Borenstein A; Sharon S; Prindull G
    Int J Cell Cloning; 1983 Oct; 1(5):343-59. PubMed ID: 6672102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of retinoic acid, 1,25-dihydroxyvitamin D3, cytosine arabinoside and alpha-interferon on bone marrow cells from patients with myelodysplastic syndromes.
    Hellström E; Robèrt KH; Soppi E; Ost A; Putkonen PO; Gahrton G
    Leuk Res; 1989; 13(12):1113-21. PubMed ID: 2615468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cytosine arabinoside on unseparated bone marrow and peripheral blood cells and on specimens enriched for myeloblasts and promyelocytes.
    Epstein J; Preisler HD; Rustum YM; Higby DJ
    Exp Hematol; 1980 Apr; 8(4):404-8. PubMed ID: 7461048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.